首页> 外文期刊>Journal of neuro-oncology. >Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy.
【24h】

Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy.

机译:胶质母细胞瘤在手术和辅助治疗之间的早期MRI变化。

获取原文
获取原文并翻译 | 示例
           

摘要

To investigate the increase in MRI contrast enhancement (CE) occurring in glioblastoma during the period between surgery and initiation of chemo-radiotherapy, thirty-seven patients with newly diagnosed glioblastoma were analyzed by early post-operative magnetic resonance (EPMR) imaging within three days of surgery and by pre-adjuvant magnetic resonance (PAMR) examination before adjuvant therapy. Areas of new CE were investigated by use of EPMR diffusion-weighted imaging and PAMR perfusion imaging (by arterial spin-labeling). PAMR was acquired, on average, 29.9 days later than EPMR (range 20-37 days). During this period an increased area of CE was observed for 17/37 patients. For 3/17 patients these regions were confined to areas of reduced EPMR diffusion, suggesting postsurgical infarct. For the other 14/17 patients, these areas suggested progression. For 11/17 patients the co-occurrence of hyperperfusion in PAMR perfusion suggested progression. PAMR perfusion and EPMR diffusion did not give consistent results for 3/17 patients for whom small new areas of CE were observed, presumably because of the poor spatial resolution of perfusion imaging. Before initiation of adjuvant therapy, areas of new CE of resected glioblastomas are frequently observed. Most of these suggest tumor progression, according to EPMR diffusion and PAMR perfusion criteria.
机译:为了研究胶质母细胞瘤在手术和化学放疗开始之间的MRI对比增强(CE)的增加,我们对3天内新诊断的胶质母细胞瘤患者进行了术后三天内的早期磁共振(EPMR)成像分析手术和辅助治疗前通过辅助前磁共振(PAMR)检查。通过使用EPMR扩散加权成像和PAMR灌注成像(通过动脉自旋标记)研究了新的CE区域。平均而言,PAMR的购买时间比EPMR的购买时间晚29.9天(范围为20-37天)。在此期间,有17/37例患者的CE面积增加。对于3/17例患者,这些区域仅限于EPMR扩散减少的区域,提示术后梗死。对于其他14/17患者,这些区域提示进展。对于11/17患者,PAMR灌注中高灌注的同时发生提示病情发展。对于3/17观察到小面积CE的患者,PAMR灌注和EPMR扩散的结果不一致,大概是由于灌注成像的空间分辨率差。在开始辅助治疗之前,经常观察到已切除的胶质母细胞瘤的新CE区域。根据EPMR扩散和PAMR灌注标准,大多数提示肿瘤进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号